Novartis lifts profit outlook as new medicines counter generic erosion (NVS:NYSE)
· seekingalpha.com
Novartis raised its 2025 profit outlook after strong demand for newer drugs beat generic pressure.
Novartis AG (NVS) improved its full-year profit outlook on Tuesday after stronger demand for newer medicines helped offset generic competition for its blockbust...